Gclc Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Gclc Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@alzheimers]
Gclc Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Gclc Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@alzheimers]
Glutamate-cysteine ligase (GCL) is a heterodimeric enzyme composed of a catalytic subunit (GCLC, 73.5 kDa) and a modifier subunit (GCLM, 30.8 kDa). GCLC contains the active site and ATP-binding domain, while GCLM modulates enzyme kinetics and sensitivity to inhibitors. The enzyme undergoes allosteric regulation and is feedback-inhibited by glutathione.
Normal Function
GCLC is the catalytic subunit of glutamate-cysteine ligase (also known as γ-glutamylcysteine synthetase), the rate-limiting enzyme in glutathione biosynthesis. This enzyme catalyzes the ATP-dependent formation of γ-glutamylcysteine from glutamate and cysteine:
Reaction: Glutamate + Cysteine + ATP → γ-Glutamylcysteine + ADP + Pi
The reaction is the rate-limiting step in glutathione (GSH) synthesis because GCLC has a low Km for cysteine and is subject to feedback inhibition by GSH. GCLC expression is regulated by:
In the nervous system, GCLC is expressed in [neurons](/entities/neurons) and glial cells, providing the foundation for glutathione-mediated antioxidant defense.
Role in Neurodegeneration
Alzheimer's Disease
GCLC expression and activity are dysregulated in AD brain
Reduced glutathione levels correlate with disease progression
GCLC polymorphisms may influence AD risk
The enzyme is a therapeutic target for enhancing neuronal antioxidant capacity
Parkinson's Disease
GCLC is critical for protecting dopaminergic neurons from oxidative stress
MPTP and 6-OHDA models show altered GCLC expression
Enhancing GCLC activity protects against dopaminergic neuron loss
GCLC polymorphisms have been associated with PD risk in some populations
Amyotrophic Lateral Sclerosis
GCLC is upregulated in ALS models and patients
Motor neurons are particularly vulnerable to glutathione depletion
Enhancing GCLC expression delays disease progression in SOD1 mutant mice
Multiple Sclerosis
GCLC expression in oligodendrocytes is crucial for myelin protection
AAV-mediated GCLC delivery shows promise in preclinical models
Clinical Trials
N-acetylcysteine has been tested in clinical trials for neurodegenerative diseases
Key Publications
Griffith OW, et al. (1999). "The role of glutamate cysteine ligase in cellular glutathione synthesis." Free Radic Biol Med. 27(9-10):922-935. [DOI:10.1016/S0891-5849(99](https://doi.org/10.1016/S0891-5849(99))00168-7
Dalton TP, et al. (2000). "Regulation of gamma-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defense." Toxicol Sci. 54(1):52-64. [DOI:10.1093/toxsci/54.1.52](https://doi.org/10.1093/toxsci/54.1.52)
McBean GJ, et al. (2015). "Glutathione metabolism in brain and motor neuron disease." Cell Mol Neurobiol. 35(2):181-191. [DOI:10.1007/s10571-014-0110-4](https://doi.org/10.1007/s10571-014-0110-4)
Overview
Gclc Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Gclc Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.